Of course, our top shareholders speaks for itself, NCM, IGO, Mark Creasy was a top shareholder before dilution but still holds a decent amount of shares. In fact Mark Creasy worked with Antipa management in looking at the ground geology for 12 months, before deal was made between them
Antipa is a junior in mineral exploration, but you only have to look at our management to see the pedigree of expertise and experience. Peter Buck is currently a director of IGO a company with a MC $5.5 billion. And what Antipa management did with Lion Ore, they turned it from a smaller scale operation into a Top 10 global Nickel miner before being bought out by the biggest Nickel miner in the world. And now management have set AZY up to be in the most enviable position of any junior, it has in fact moulded AZY as a company alongside the biggest and best miners in the world.
Market action may not indicate it, but there really is an exciting exploration story going on @ the moment
- Forums
- ASX - By Stock
- AZY
- Antipa v Greatland Gold value for money
Antipa v Greatland Gold value for money, page-27
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZY (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $51.81M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $87.49K | 7.534M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 20884956 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 11814202 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 20884956 | 0.011 |
54 | 20852853 | 0.010 |
33 | 13809155 | 0.009 |
18 | 8352820 | 0.008 |
4 | 2250000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 11814202 | 13 |
0.013 | 11067216 | 8 |
0.014 | 7141789 | 10 |
0.015 | 4568929 | 9 |
0.016 | 4415631 | 10 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AZY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online